Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma
Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma
Active, not recruiting · NCT05315258 · Registry updated 2025-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Uveal Neoplasms, eye disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, skin disorder, skin neoplasm, uveal disorder, uveal melanoma | Active, not recruiting | Phase 2 | 2025-07-17 | NCT05315258 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Immunocore Ltd | 12 |
| University of Oxford | 213 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cambridge University Hospitals NHS Foundation Trust (Screening only) | Cambridge | United Kingdom | 1 |
| Churchill Hospital, Oxford University Hospitals NHS Trust | Oxford | United Kingdom | 1 |
| Mount Vernon Cancer Centre | Middlesex | United Kingdom | 1 |
| Newcastle upon Tyne Hospitals NHS Foundation Trust | Newcastle | United Kingdom | 3 |
| Sheffield Teaching Hospitals NHS Foundation Trust (Screening only) | Sheffield | United Kingdom | 1 |
| The Beatson West of Scotland Cancer Centre | Glasgow | United Kingdom | 3 |
| The Christie Hospital | Manchester | United Kingdom | 13 |
| The Clatterbridge Cancer Centre | Liverpool | United Kingdom | 2 |
| University College London Hospital | London | United Kingdom | 32 |
| University Hospital Southampton NHS Foundation Trust | Southampton | United Kingdom | 24 |